tiprankstipranks
Oramed Pharmaceuticals (ORMP)
NASDAQ:ORMP
Holding ORMP?
Track your performance easily

Oramed Pharm (ORMP) Technical Analysis

511 Followers

Technical Sentiment

Overall Consensus
Buy
10Bullish
5Neutral
6Bearish
Technical Analysis Consensus
Buy
3Bullish
5Neutral
1Bearish
Moving Average Consensus
Buy
7Bullish
0Neutral
5Bearish
Oramed Pharmaceuticals’s (ORMP) Moving Averages Convergence Divergence (MACD) indicator is -0.02, suggesting Oramed Pharmaceuticals is a Sell.
Oramed Pharmaceuticals’s (ORMP) 20-Day exponential moving average is 2.32, while Oramed Pharmaceuticals’s (ORMP) share price is $2.37, making it a Buy.
Oramed Pharmaceuticals’s (ORMP) 50-Day exponential moving average is 2.35, while Oramed Pharmaceuticals’s (ORMP) share price is $2.37, making it a Buy.

Oramed Pharm (ORMP) Pivot Points

Nov 26, 2024, 11:00 PM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
2.21
2.25
2.30
2.34
2.39
2.43
2.48
Fibonacci
2.25
2.29
2.31
2.34
2.38
2.40
2.43
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Oramed Pharm (ORMP) Moving Averages

Nov 26, 2024, 11:00 PM
Period
Simple
Exponential
MA5
2.31Buy
2.32Buy
MA10
2.30Buy
2.31Buy
MA20
2.32Buy
2.32Buy
MA50
2.36Sell
2.35Buy
MA100
2.40Sell
2.38Sell
MA200
2.50Sell
2.45Sell
Oramed Pharmaceuticals’s (ORMP) 10-Day exponential moving average is 2.31, while Oramed Pharmaceuticals’s (ORMP) share price is $2.37, making it a Buy.
Oramed Pharmaceuticals’s (ORMP) 100-Day exponential moving average is 2.38, while Oramed Pharmaceuticals’s (ORMP) share price is $2.37, making it a Sell.
Oramed Pharmaceuticals’s (ORMP) stock price is $2.37 and Oramed Pharmaceuticals’s (ORMP) 50-day simple moving average is 2.36, creating a Sell signal.
Oramed Pharmaceuticals’s (ORMP) stock price is $2.37 and Oramed Pharmaceuticals’s (ORMP) 100-day simple moving average is 2.40, creating a Sell signal.
Oramed Pharmaceuticals’s (ORMP) stock price is $2.37 and Oramed Pharmaceuticals’s (ORMP) 200-day simple moving average is 2.50, creating a Sell signal.

Oramed Pharm (ORMP) Technical Indicators

Nov 26, 2024, 11:00 PM
Name
Value
Implied Action
RSI (14)
51.89
Neutral
STOCH (9,6)
76.03
Neutral
STOCHRSI (14)
67.78
Neutral
MACD (12,26)
-0.02
Sell
ADX (14)
12.68
Buy
Williams %R
-26.67
Buy
CCI (14)
51.96
Neutral
ATR (14)
0.09
-
Ultimate Oscillator
43.04
Neutral
ROC
0.00
-
Oramed Pharmaceuticals’s (ORMP) Relative Strength Index (RSI) is 51.89, creating a Neutral signal.
Oramed Pharmaceuticals’s (ORMP) Trend Strength Indicator (ADX) is 12.68, creating a Buy signal.
Oramed Pharmaceuticals’s (ORMP) Commodity Channel Index (CCI) is 51.96, creating a Neutral signal.

FAQ

Is ORMP a Buy, Hold, or Sell?
Based on ORMP’s technical indicators, ORMP is a Buy.
    What is ORMP’s RSI (14)?
    ORMP’s RSI (14) is 51.89, which suggests ORMP is a Neutral.
      What is ORMP’s MACD?
      ORMP’s MACD is -0.02, which suggests ORMP is a Sell.
        What is ORMP’s 5-day moving average?
        ORMP’s 5-day moving average is 2.31, which suggests ORMP is a Buy.
          What is ORMP’s 20-day moving average?
          ORMP 20-day moving average is 2.32, which suggests ORMP is a Buy.
            What is ORMP’s 50-day moving average?
            ORMP’s 50-day moving average is 2.36, which suggests ORMP is a Sell.
              What is ORMP’s 200-day moving average?
              ORMP’s 200-day moving average is 2.50, which suggests ORMP is a Sell.
                What is ORMP’s Williams % R (14)?
                ORMP’s Williams % R (14) is -26.67, which suggests ORMP is a Buy.
                  What is ORMP’s CCI (14)?
                  ORMP’s CCI (14) is 51.96, which suggests ORMP is a Neutral.
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis